BFM
MRNA icon

Boothbay Fund Management’s Moderna MRNA Stock Holding History

Boothbay Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54,800
Closed -$1.62M – 2325
2025
Q4 		$1.62M Sell
54,800
-130,900
-70% -$3.56M 0.02% 644
2025
Q3 		$4.8M Buy
+185,700
New +$5.18M 0.07% 321
2025
Q1 		– Sell
-28,900
Closed -$1.2M – 1636
2024
Q4 		$1.2M Buy
+28,900
New +$1.38M 0.03% 587
2024
Q3 		– Sell
-3,100
Closed -$368K – 1813
2024
Q2 		$368K Buy
+3,100
New +$392K 0.01% 1089
2024
Q1 		– Sell
-9,300
Closed -$925K – 1807
2023
Q4 		$925K Sell
9,300
-41,600
-82% -$3.5M 0.02% 755
2023
Q3 		$5.26M Buy
+50,900
New +$5.68M 0.12% 202
2022
Q4 		– Sell
-69,600
Closed -$8.23M – 2285
2022
Q3 		$8.23M Buy
+69,600
New +$10.6M 0.21% 72
2022
Q2 		– Sell
-2,300
Closed -$396K – 2513
2022
Q1 		$396K Sell
2,300
-76,000
-97% -$12.8M 0.01% 1433
2021
Q4 		$19.9M Buy
+78,300
New +$22.9M 0.47% 20
2021
Q2 		– Sell
-659
Closed -$8.63M – 2014
2021
Q1 		$8.63M Sell
659
-793
-55% -$115K 0.32% 42
2020
Q4 		$15.2M Buy
1,452
+330
+29% +$33.4K 0.56% 17
2020
Q3 		$7.94M Buy
1,122
+904
+415% +$63K 0.48% 22
2020
Q2 		$1.4M Buy
+218
New +$11.9K 0.1% 286

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's MRNA Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Moderna (MRNA) in Q1 2026: 7,772 shares worth $395K. The stake represents 0.01% of the portfolio and ranks #1476 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in MRNA as recently as Q3 2025.

Boothbay Fund Management first reported a position in MRNA in Q4 2018 and has held it in 11 quarters since. The position peaked at $925K in Q4 2020. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Boothbay Fund Management held 7,772 shares of Moderna worth $395K as of Q1 2026.
  • Moderna was a new Boothbay Fund Management position in Q1 2026.
  • Moderna made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1476 holding.
  • Boothbay Fund Management first reported a position in Moderna in Q4 2018 and has held it in 11 quarters since.
  • Boothbay Fund Management's Moderna position peaked at $925K in Q4 2020.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.